Amedisys

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Amedisys reports robust Q4 earnings, eyes growth amidst operational challenges

Amedisys showcases strong financial performance and strategic initiatives for 2023, focusing on growth and operational optimization.
Despite challenges like labor market issues and operational hurdles, the company remains confident in its growth strategies and talent management.
Opportunities in negotiations with payers, talent acquisition, and operational enhancements position Amedisys for continued success and revenue growth.
With a positive outlook for 2023 and a resilient approach to challenges, Amedisys is poised for steady growth and operational improvements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

BATON ROUGE, La., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2021.

Amedisys Reports Second Quarter 2021 Financial Results, Closing of Contessa Acquisition, Expansion of Credit Facility and Authorization of New $100 Million Share Repurchase Program

Amedisys, Inc. (NASDAQ:AMED) is one of the largest home health providers and second largest hospice care provider in the U.S. In the thick of earnings season , the company will step into the confessional tomorrow after the close.

Healthcare Stock Needs a Post-Earnings Pop

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amedisys announces the acquisition of Contessa Health, a leader in hospital-at-home services. Despite the near-term margin drag, the added growth potential and strategic benefits should drive upside to the longer-term earnings trajectory.

Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity

The latest development remains in line with Amedisys' (AMED) ongoing efforts to expand footprint in key markets.

Amedisys (AMED) Latest New York Assets Buyout Aids Home Health

Leveraging on VNA's home health and hospice care legacy, Amedisys (AMED) expects to provide additional scale and resources.

Amedisys' (AMED) VNA Assets Buyout Boosts Home Health-Hospice

Amedisys (AMED) inks deal to acquire Contessa Health to boost home health and hospice services business.

Amedisys' (AMED) Contessa Buyout to Boost Home Health Business

Amedisys (AMED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Amedisys (AMED) Soars 6.7%: Is Further Upside Left in the Stock?

Strategic acquisition will add tech-enabled, higher-acuity hospital at home and skilled-nursing facility at home services, advanced claims analytics platform, network management and additional risk-taking capabilities to Amedisys' range of home-based services Strategic acquisition will add tech-enabled, higher-acuity hospital at home and skilled-nursing facility at home services, advanced claims analytics platform, network management and additional risk-taking capabilities to Amedisys' range of home-based services

Amedisys Announces Agreement to Acquire Contessa Health, Creating a Comprehensive Home Healthcare Delivery Platform

DaVita

DVA vs. AMED: Which Stock Is the Better Value Option?

DVA or AMED: Which Is the Better Value Stock Right Now?

Advanced Micro Devices

AtriCure

Deere & Company

Zscaler

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Deere & Advanced Micro Devices.

These are Wall Street's top analysts favorite stocks heading into June

DVA vs. AMED: Which Stock Should Value Investors Buy Now?

Investors are optimistic about Amedisys (AMED) on bright Personal Care prospects, and strategic acquisitions and partnerships.

Here's Why You Should Buy Amedisys (AMED) Stock Now

The acquisition is going to expand Amedisys' (AMED) presence in Omaha and Council Bluffs' healthcare communities.

Amedisys (AMED) to Buy VNA Hospice, Home Health, Expand in NE

BATON ROUGE, La., May 10, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, and Chris Gerard, President and Chief Operating Officer, will present at the 2021 RBC Capital Markets Healthcare Conference on Tuesday, May 18, 2021.

Amedisys to Present at the 2021 RBC Capital Markets Global Healthcare Conference

BATON ROUGE, La., May 03, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has closed on its acquisition of regulatory assets that allow the Company to conduct home health care operations in Randolph County, N.C.

Amedisys to Open Randolph County Home Health Care Center

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q1 2021 Results - Earnings Call Transcript

Amedisys' (AMED) first-quarter 2021 revenues improves year over year on solid growth in the Home Health and Hospice divisions.

Amedisys (AMED) Q1 Earnings Beat Estimates, 2021 View Up

BATON ROUGE, La., April 28, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2021.

Amedisys Reports First Quarter 2021 Financial Results Updates 2021 Guidance

BATON ROUGE, La., April 27, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, in collaboration with Sound Physicians, a leading physician practice partner to health systems and plans, physician groups and post-acute providers, will launch the Home Health Advanced Program in the southeastern United States. The program is part of both Amedisys' and Sound Physicians' efforts to provide the highest quality care to patients in their home upon their discharge from an acute setting.

Amedisys and Sound Physicians to Launch “Home Health Advanced” Pilot Program

Amedisys (NASDAQ:AMED) announces its next round of earnings this Wednesday, April 28. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings announcement.

Earnings Outlook For Amedisys

Growth in Home Health and Hospice along with recent innovation and acquisitions is expected to have contributed to Amedisys (AMED) top-line growth in Q1.

Amedisys (AMED) to Report Q1 Earnings: What's in Store?

Amedisys' (AMED) new agreement to acquire Randolph Country regulatory assets will broaden the company's footprint in the Home Health care market.

Amedisys (AMED) Inks Deal to Extend Home Health Care Operations

BATON ROUGE, La., April 14, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, will report results for the first quarter ended March 31, 2021, after the market closes on April 28, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on April 29, 2021.

News for Amedisys Stock (AMED)